Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Investigating a Kinase as a Target for Alzheimer’s Disease

FY 2018-19

Summary
Alzheimer's disease (AD) is the most common form of dementia, accounting for 60-70 percent of the approximately 50 million dementia cases worldwide, as reported by the World Health Organization. Patients experiencing the neurodegeneration associated with this disease do not have treatment options that interfere with disease progression; current treatments only alleviate symptoms. This project will investigate the protein calcium/calmodulin dependant protein kinase 1 delta (CaMK1D) as a novel target for late-onset Alzheimer's disease (LOAD). Several studies have linked CaMK1D to AD, including genetic studies and studies examining the amount of CaMK1D and specific fragments of CaMK1D in the brains of AD patients. Here, three main hypotheses will be explored. First, that CaMK1D is modified, cut into smaller pieces, and hyperactive during AD. Second, that the hyperactivity of CaMK1D leads to modification of other AD related proteins to resemble their state in AD, and lastly, the use of specific inhibitors for CaMK1D can control the progression of AD type pathology in cell culture. To explore these hypotheses, neuronal cell culture methods that mimic the AD state biochemically will be used as a model. Determination of the state and function of CaMK1D in AD models, as well as its contribution to AD pathways, represents a new strategy for stopping progression of AD.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406611
Name
Grant Paige E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating a Kinase as a Target for Alzheimer’s Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Alzheimer'S Disease; Biochemistry; Camk1d; Kinase; Primary Cell Culture
Abstract
Alzheimer's disease (AD) is the most common form of dementia, accounting for 60-70 percent of the approximately 50 million dementia cases worldwide, as reported by the World Health Organization. Patients experiencing the neurodegeneration associated with this disease do not have treatment options that interfere with disease progression; current treatments only alleviate symptoms. This project will investigate the protein calcium/calmodulin dependant protein kinase 1 delta (CaMK1D) as a novel target for late-onset Alzheimer's disease (LOAD). Several studies have linked CaMK1D to AD, including genetic studies and studies examining the amount of CaMK1D and specific fragments of CaMK1D in the brains of AD patients. Here, three main hypotheses will be explored. First, that CaMK1D is modified, cut into smaller pieces, and hyperactive during AD. Second, that the hyperactivity of CaMK1D leads to modification of other AD related proteins to resemble their state in AD, and lastly, the use of specific inhibitors for CaMK1D can control the progression of AD type pathology in cell culture. To explore these hypotheses, neuronal cell culture methods that mimic the AD state biochemically will be used as a model. Determination of the state and function of CaMK1D in AD models, as well as its contribution to AD pathways, represents a new strategy for stopping progression of AD.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Grant, Paige E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~